Globus Medical Pre-Tax Profit Margin 2010-2025 | GMED
Current and historical pre-tax profit margin for Globus Medical (GMED) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Globus Medical pre-tax profit margin for the three months ending March 31, 2025 was .
| Globus Medical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $2.51B | $0.23B | 9.32% |
| 2024-12-31 | $2.52B | $0.12B | 4.80% |
| 2024-09-30 | $2.48B | $0.12B | 4.88% |
| 2024-06-30 | $2.24B | $0.07B | 2.99% |
| 2024-03-31 | $1.90B | $0.09B | 4.95% |
| 2023-12-31 | $1.57B | $0.17B | 10.57% |
| 2023-09-30 | $1.23B | $0.20B | 16.54% |
| 2023-06-30 | $1.10B | $0.26B | 23.79% |
| 2023-03-31 | $1.07B | $0.26B | 24.04% |
| 2022-12-31 | $1.02B | $0.24B | 23.75% |
| 2022-09-30 | $1.00B | $0.20B | 20.12% |
| 2022-06-30 | $0.98B | $0.19B | 19.90% |
| 2022-03-31 | $0.96B | $0.17B | 17.88% |
| 2021-12-31 | $0.96B | $0.18B | 18.79% |
| 2021-09-30 | $0.94B | $0.22B | 23.59% |
| 2021-06-30 | $0.93B | $0.22B | 23.84% |
| 2021-03-31 | $0.83B | $0.15B | 18.18% |
| 2020-12-31 | $0.79B | $0.13B | 15.84% |
| 2020-09-30 | $0.77B | $0.12B | 15.23% |
| 2020-06-30 | $0.75B | $0.11B | 14.84% |
| 2020-03-31 | $0.79B | $0.18B | 22.67% |
| 2019-12-31 | $0.79B | $0.19B | 24.17% |
| 2019-09-30 | $0.77B | $0.18B | 23.90% |
| 2019-06-30 | $0.74B | $0.18B | 24.23% |
| 2019-03-31 | $0.72B | $0.18B | 25.38% |
| 2018-12-31 | $0.71B | $0.19B | 26.54% |
| 2018-09-30 | $0.69B | $0.19B | 27.75% |
| 2018-06-30 | $0.68B | $0.19B | 27.56% |
| 2018-03-31 | $0.65B | $0.18B | 26.91% |
| 2017-12-31 | $0.64B | $0.17B | 26.73% |
| 2017-09-30 | $0.61B | $0.16B | 25.33% |
| 2017-06-30 | $0.60B | $0.16B | 26.34% |
| 2017-03-31 | $0.58B | $0.16B | 26.68% |
| 2016-12-31 | $0.56B | $0.16B | 27.84% |
| 2016-09-30 | $0.56B | $0.18B | 31.89% |
| 2016-06-30 | $0.56B | $0.18B | 32.19% |
| 2016-03-31 | $0.55B | $0.18B | 32.19% |
| 2015-12-31 | $0.55B | $0.17B | 31.50% |
| 2015-09-30 | $0.53B | $0.16B | 29.14% |
| 2015-06-30 | $0.51B | $0.15B | 29.04% |
| 2015-03-31 | $0.49B | $0.14B | 29.21% |
| 2014-12-31 | $0.48B | $0.14B | 29.05% |
| 2014-09-30 | $0.46B | $0.13B | 28.42% |
| 2014-06-30 | $0.45B | $0.13B | 28.00% |
| 2014-03-31 | $0.44B | $0.11B | 23.70% |
| 2013-12-31 | $0.43B | $0.10B | 23.73% |
| 2013-09-30 | $0.42B | $0.10B | 23.81% |
| 2013-06-30 | $0.41B | $0.10B | 23.77% |
| 2013-03-31 | $0.40B | $0.12B | 29.22% |
| 2012-12-31 | $0.39B | $0.11B | 29.46% |
| 2012-09-30 | $0.37B | $0.11B | 29.14% |
| 2012-06-30 | $0.36B | $0.11B | 29.75% |
| 2012-03-31 | $0.35B | $0.10B | 29.31% |
| 2011-12-31 | $0.33B | $0.10B | 29.31% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.062B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $200.019B | 87.61 |
| Thermo Fisher Scientific (TMO) | United States | $150.378B | 18.19 |
| Edwards Lifesciences (EW) | United States | $45.620B | 29.91 |
| Alcon (ALC) | Switzerland | $42.878B | 28.98 |
| IDEXX Laboratories (IDXX) | United States | $41.997B | 48.26 |
| DexCom (DXCM) | United States | $33.619B | 51.96 |
| IQVIA Holdings (IQV) | United States | $25.495B | 14.28 |
| Mettler-Toledo (MTD) | United States | $24.204B | 28.78 |
| STERIS (STE) | Ireland | $23.962B | 26.39 |
| Waters (WAT) | United States | $20.610B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.452B | 0.00 |
| Hologic (HOLX) | United States | $14.055B | 15.27 |
| Sysmex ADR (SSMXY) | Japan | $10.248B | 29.07 |
| Penumbra (PEN) | United States | $10.006B | 78.54 |
| Masimo (MASI) | United States | $8.931B | 32.94 |
| Teleflex (TFX) | United States | $5.411B | 8.93 |
| Glaukos (GKOS) | United States | $5.296B | 0.00 |
| TransMedics (TMDX) | United States | $4.586B | 99.70 |
| Integer Holdings (ITGR) | United States | $4.218B | 22.10 |
| PROCEPT BioRobotics (PRCT) | United States | $3.599B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.445B | 14.56 |
| Nihon Kohden (NHNKY) | Japan | $2.253B | 25.84 |
| Veracyte (VCYT) | United States | $2.113B | 29.65 |
| Elekta AB (EKTAY) | Sweden | $1.973B | 17.74 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.376B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 116.48 |
| Pulse Biosciences (PLSE) | United States | $1.098B | 0.00 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.033B | 5.49 |
| Beta Bionics (BBNX) | United States | $0.848B | 0.00 |
| SiBone (SIBN) | United States | $0.812B | 0.00 |
| IRadimed (IRMD) | United States | $0.767B | 38.94 |
| RxSight (RXST) | United States | $0.606B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.588B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.87 |
| Mesa Laboratories (MLAB) | United States | $0.544B | 12.76 |
| OrthoPediatrics (KIDS) | United States | $0.507B | 0.00 |
| AxoGen (AXGN) | United States | $0.492B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.436B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.420B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.364B | 9.69 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.359B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.300B | 0.00 |
| Neuronetics (STIM) | United States | $0.252B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.235B | 14.24 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.198B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| CVRx (CVRX) | United States | $0.168B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.131B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 50.30 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |